Cobram Estate Olives stock closed at A$2.81 after a rough run where the share price has fallen about 32% over three months. Yet the headline from these earnings is not the share price. It is the squeeze on profitability after a heavy year of investment and acquisition.
Normalized EBITDA of A$61.4m sits against a much slimmer A$13.0m in normalized earnings before tax once one off items tied to the California Olive Ranch deal are counted. For anyone looking beyond today’s price reaction, the key question now is how that earnings squeeze may influence the returns on all this new capital over the coming years.
Is Cobram Estate Olives now an overlooked growth story trading at a discount, or is this compressed profit line a warning signal about the price you are paying for that growth? Compare the DCF gap and revenue multiples side by side on our valuation analysis for Cobram Estate Olives.Prefer clean charts instead of another wall of earnings tables and footnotes? See Cobram Estate Olives' full financial picture, including a clear view of its profitability and earnings trend shifts, in our company report for Cobram Estate Olives.
Bulls argue Cobram Estate is a premium, vertically integrated olive oil producer with structural growth as new groves mature and U.S. brands scale. The latest result partly supports that story. Group revenue to A$273.2m over the TTM to FY 2026 H2 and normalized EBITDA of A$61.4m show the business still generates meaningful operating profit even in an Australian off year and with only three months of California Olive Ranch. Management has moved quickly on U.S. integration, with most of the targeted roughly US$12m annualized synergies already implemented. Mature hectare expansion plans in Australia and committed new plantings in California also keep the growth pipeline intact. However, normalized earnings before tax dropping to A$13.0m and operating cash flow before interest and tax falling to A$47.5m highlight that the promised operating leverage is not yet coming through in headline profitability.
The bear narrative focuses on agricultural volatility, rising costs and heavy U.S. capital spend putting pressure on Cobram Estate earnings and cash. This result gives that view more weight. Net income from continuing operations swung from a A$49.6m profit over the prior TTM period to a A$4.2m loss, even with a A$33.5m tax benefit. Normalized EBITDA slipped from A$76.1m to A$61.4m while temporary water costs of about A$6m and softer bulk pricing hit Australian margins. Operating cash flow before interest and tax fell from A$83m to A$47.5m as the company lifted oil purchases and absorbed one off and transaction costs. Growth capex of roughly A$101m, mainly in the U.S., pushed the net debt ratio up to 35.6%. The share price decline of roughly 32% over three months suggests investors are treating this earnings compression and leverage drift as meaningful execution risk.
After a swing from profit to loss and a higher net debt ratio, investors may wonder if this earnings strain is an early warning or part of a wider pattern. Review our risk analysis for Cobram Estate Olives which shows 1 important warning signIf Cobram Estate Olives' swing from profit to loss and the recent share price decline has your attention, register for free with Simply Wall St and add it to a Watchlist to track price against fair value and watch how the thesis evolves. After you take a position, keep your decisions clear with the Portfolio Command Center which highlights only the most important developments for your holdings. For a longer term view, use the Community to see how other investors are interpreting the same set of results and balance sheet moves. By spotting potential catalysts and risks early, you can react faster and stay ahead of the market.
Fresh ideas can move fast. Some stocks are building quiet breakout momentum while they are still under the radar for now. Check these curated lists before the window narrows and get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com